Please assess the completion status of the following clinical trial:

Trial Title: Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* adult confirmed HIV-1 infection~* no previous treatment with antiretroviral drugs or interleukin-2~* CD4 count ≥ 500/mm3~* no active opportunistic infection~* written informed consent~Exclusion Criteria:~* non barrier contraception in women of child bearing potential, pregnant or breastfeeding woman, pregnancy project within the next 2 years~* HIV-2 infection (with or without HIV-1), recent HIV primary infection, resistance to trial drugs at study entry, Ag HBs+, HCV requiring specific therapy~* previous history of cerebrovascular accident or coronary heart disease, splenectomy~* previous CD4 count \< 400/mm3~* CD4 percentage \< 15%~* hemoglobin \< 8 g/dl, neutrophils \< 750/mm3, platelets \< 100.000/mm3, creatinine clearance \< 50 ml/mn, AST or ALT or total bilirubin \> 3 ULN

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intermittent treatment (Type: EXPERIMENTAL): 6 months on antiretroviral treatment and 6 months off treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).